We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Differences Between Two Cancer-promoting Enzymes Discovered

News   Mar 28, 2019 | Original story from the University of Würzburg

 
Differences Between Two Cancer-promoting Enzymes Discovered

Structures of the catalytic domains of USP28 and USP25: USP28 is a constitutively active dimer and can bind and process ubiquitin (orange) at any time. In contrast, USP25 is a tetramer composed of two inter-linked USP28-like dimers (blue / gray and yellow / green) and this arrangement prevents binding of the substrate rendering the enzyme inactive. Credit: Rudolf Virchow Center of experimental biomedicine / University of Wuerzburg

 
 
 

RELATED ARTICLES

The Power of Collaboration: Tackling Pharmaceutical Challenges

News

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

Worms Reveal Critical Step in Insulin Synthesis

News

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.

READ MORE

A New Treatment For Elephantiasis?

News

Using RNA sequencing techniques, researchers have discovered that an experimental cancer drug could be used to treat a disabling parasitic disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE